Traverse Biosciences is commercializing an edible prescription medication for the prevention and control of canine periodontal disease, which affects approximately 80% of dogs over the age of two.
Company (Alive / Active)
25 Health Sciences Drive
Stony Brook, 11790
New York, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)